Histidine

Histidine

SCHEMBL285814

CSCC[C@H](N)C(=O)O.C[C@@H](O)[C@H](N)C(=O)O.C[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O.N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Histidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.38
THRB P10828 1/20 0.33
CPB2 Q96IY4 3/20 0.32
CPB1 P15086 2/20 0.32
ITGB3 P05106 1/20 0.32
ITGA2B P08514 1/20 0.32
CYP3A4 P08684 1/20 0.31
SLC7A5 Q01650 1/20 0.31
ARG1 P05089 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL285636 0.98 GSR (0.39) GSRTHRBCPB2CPB1ITGB3
Histidine SCHEMBL285813 0.92 GSR (0.33) GSRTHRBITGB3ITGA2B
Histidine SCHEMBL23363055 0.92 GSR (0.44) GSRTHRBCPB2CPB1ITGB3
Histidine SCHEMBL285488 0.92 GSR (0.44) GSRTHRBCPB2CPB1ITGB3
Histidine SCHEMBL18297992 0.91 GSR (0.46) GSRTHRBCPB2CPB1ITGB3
Histidine SCHEMBL9020921 0.88 GSR (0.49) GSRTHRBCPB2CPB1ITGB3
Histidine SCHEMBL9244290 0.87 GSR (0.42) GSRTHRBCPB2CPB1ITGB3
Histidine SCHEMBL9244278 0.87 GSR (0.42) GSRTHRBCPB2CPB1ITGB3
Histidine SCHEMBL2029768 0.87 SLC7A5 (0.34) CYP3A4SLC7A5
Histidine SCHEMBL28219638 0.85 BHMT (0.32) CYP3A4SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135931-A1 METHOD OF MODIFYING SERINE PROTEASE INHIBITORS NATURAL ENVIRONMENT RESEARCH COUNCIL (GB) 2012-05-31 US disclosed
EP-2427487-A2 METHOD OF MODIFYING SERINE PROTEASE INHIBITORS Natural Environment Research Council (GB) 2012-03-14 EP disclosed
WO-2010128285-A2 METHOD OF MODIFYING SERINE PROTEASE INHIBITORS NATURAL ENVIRONMENT RESEARCH COUNCIL (GB) 2010-11-11 WO disclosed